M
Modern Age
On a mission to add millions of years of healthy life expectancy to the world
About Modern Age
Modern Age is a health-focused startup that aims to extend the healthspan of individuals by preventing age-related decline through a holistic and personalized approach to medicine. The company operates in the health and wellness market, serving clients who are interested in maintaining their health and slowing down the aging process.
Their business model revolves around a comprehensive Aging Wellness Assessment, which includes a blood draw that can be done at home, in the lab, or at their clinics. The assessment also includes digital tests to evaluate cognitive function and visible age. After the assessment, clients meet with a board-certified clinician for a review of their results and receive a personalized plan. The company then offers a 6-month Optimization Program, tailored to the client's needs and results.
The team at Modern Age is composed of highly qualified professionals, including Dr. Shoma Datta-Thomas, the Head of Wellness, and Dr. Anant Vinjamoori, the Chief Medical Officer. They also have a Doctor of Nursing Practice, a health coach, and a Nurse Practitioner specializing in cosmetic dermatology.
Modern Age generates revenue through the fees charged for their assessments, consultations, and the Optimization Program. They also offer skin treatments and hormone panels, which provide additional sources of income.
The company has received positive feedback from clients, who appreciate the personalized approach and the serene environment of their clinics.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2020
- Headquarters
- New York City, United States
- Employees
- 86
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Telemedicine, Precision Medicine, Longevity
- Business model
- SaaS
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2021 | $27M | $108M | Juxtapose · Oak HC/FT | — |
| SEEDEquity / VC | Jul 2021 | $6M | $24M | Juxtapose | — |
Growth signals
Latest recorded traffic for Modern Age is 41K monthly website visits, up 24.2% over the last three months. Modern Age's team grew 2.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Juxtapose
Series A1 investor entered at this stage
Oak HC/FT
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Modern Age on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Modern Age’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







